UniProt ID | 6PGD_HUMAN | |
---|---|---|
UniProt AC | P52209 | |
Protein Name | 6-phosphogluconate dehydrogenase, decarboxylating | |
Gene Name | PGD | |
Organism | Homo sapiens (Human). | |
Sequence Length | 483 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Catalyzes the oxidative decarboxylation of 6-phosphogluconate to ribulose 5-phosphate and CO(2), with concomitant reduction of NADP to NADPH.. | |
Protein Sequence | MAQADIALIGLAVMGQNLILNMNDHGFVVCAFNRTVSKVDDFLANEAKGTKVVGAQSLKEMVSKLKKPRRIILLVKAGQAVDDFIEKLVPLLDTGDIIIDGGNSEYRDTTRRCRDLKAKGILFVGSGVSGGEEGARYGPSLMPGGNKEAWPHIKTIFQGIAAKVGTGEPCCDWVGDEGAGHFVKMVHNGIEYGDMQLICEAYHLMKDVLGMAQDEMAQAFEDWNKTELDSFLIEITANILKFQDTDGKHLLPKIRDSAGQKGTGKWTAISALEYGVPVTLIGEAVFARCLSSLKDERIQASKKLKGPQKFQFDGDKKSFLEDIRKALYASKIISYAQGFMLLRQAATEFGWTLNYGGIALMWRGGCIIRSVFLGKIKDAFDRNPELQNLLLDDFFKSAVENCQDSWRRAVSTGVQAGIPMPCFTTALSFYDGYRHEMLPASLIQAQRDYFGAHTYELLAKPGQFIHTNWTGHGGTVSSSSYNA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
25 | Acetylation | LILNMNDHGFVVCAF EEEECCCCCEEEEEE | 26.96 | - | |
25 | Ubiquitination | LILNMNDHGFVVCAF EEEECCCCCEEEEEE | 26.96 | - | |
25 | Acetylation | LILNMNDHGFVVCAF EEEECCCCCEEEEEE | 26.96 | 19608861 | |
25 | Ubiquitination | LILNMNDHGFVVCAF EEEECCCCCEEEEEE | 26.96 | 19608861 | |
35 | Ubiquitination | VVCAFNRTVSKVDDF EEEEEECCCCCHHHH | 30.18 | - | |
35 | Phosphorylation | VVCAFNRTVSKVDDF EEEEEECCCCCHHHH | 30.18 | 28450419 | |
37 | Phosphorylation | CAFNRTVSKVDDFLA EEEECCCCCHHHHHH | 26.75 | 29978859 | |
38 | Ubiquitination | AFNRTVSKVDDFLAN EEECCCCCHHHHHHH | 45.40 | 21890473 | |
38 | Ubiquitination | AFNRTVSKVDDFLAN EEECCCCCHHHHHHH | 45.40 | 21890473 | |
38 | Acetylation | AFNRTVSKVDDFLAN EEECCCCCHHHHHHH | 45.40 | 23954790 | |
38 | Malonylation | AFNRTVSKVDDFLAN EEECCCCCHHHHHHH | 45.40 | 26320211 | |
38 | Ubiquitination | AFNRTVSKVDDFLAN EEECCCCCHHHHHHH | 45.40 | 21890473 | |
46 | Acetylation | VDDFLANEAKGTKVV HHHHHHHCCCCCCEE | 46.26 | - | |
46 | Ubiquitination | VDDFLANEAKGTKVV HHHHHHHCCCCCCEE | 46.26 | - | |
46 | Acetylation | VDDFLANEAKGTKVV HHHHHHHCCCCCCEE | 46.26 | 19608861 | |
46 | Ubiquitination | VDDFLANEAKGTKVV HHHHHHHCCCCCCEE | 46.26 | 19608861 | |
48 | 2-Hydroxyisobutyrylation | DFLANEAKGTKVVGA HHHHHCCCCCCEECC | 62.02 | - | |
48 | Malonylation | DFLANEAKGTKVVGA HHHHHCCCCCCEECC | 62.02 | 26320211 | |
48 | Ubiquitination | DFLANEAKGTKVVGA HHHHHCCCCCCEECC | 62.02 | 21906983 | |
50 | Phosphorylation | LANEAKGTKVVGAQS HHHCCCCCCEECCHH | 21.69 | 22210691 | |
51 | Malonylation | ANEAKGTKVVGAQSL HHCCCCCCEECCHHH | 43.52 | 32601280 | |
51 | Ubiquitination | ANEAKGTKVVGAQSL HHCCCCCCEECCHHH | 43.52 | - | |
57 | Phosphorylation | TKVVGAQSLKEMVSK CCEECCHHHHHHHHH | 40.66 | 22210691 | |
59 | Ubiquitination | VVGAQSLKEMVSKLK EECCHHHHHHHHHCC | 49.35 | 21890473 | |
59 | Ubiquitination | VVGAQSLKEMVSKLK EECCHHHHHHHHHCC | 49.35 | 21890473 | |
59 | 2-Hydroxyisobutyrylation | VVGAQSLKEMVSKLK EECCHHHHHHHHHCC | 49.35 | - | |
59 | Acetylation | VVGAQSLKEMVSKLK EECCHHHHHHHHHCC | 49.35 | 19608861 | |
59 | Malonylation | VVGAQSLKEMVSKLK EECCHHHHHHHHHCC | 49.35 | 26320211 | |
59 | Ubiquitination | VVGAQSLKEMVSKLK EECCHHHHHHHHHCC | 49.35 | 21890473 | |
63 | Acetylation | QSLKEMVSKLKKPRR HHHHHHHHHCCCCCE | 30.84 | 19608861 | |
74 | Acetylation | KPRRIILLVKAGQAV CCCEEEEEEECCHHH | 2.33 | - | |
76 | 2-Hydroxyisobutyrylation | RRIILLVKAGQAVDD CEEEEEEECCHHHHH | 46.93 | - | |
76 | Acetylation | RRIILLVKAGQAVDD CEEEEEEECCHHHHH | 46.93 | 19608861 | |
87 | Acetylation | AVDDFIEKLVPLLDT HHHHHHHHHHHHHCC | 50.39 | 21466224 | |
94 | Phosphorylation | KLVPLLDTGDIIIDG HHHHHHCCCCEEEEC | 36.40 | 24076635 | |
104 | Phosphorylation | IIIDGGNSEYRDTTR EEEECCCHHHCCCCH | 39.00 | 21712546 | |
106 | Ubiquitination | IDGGNSEYRDTTRRC EECCCHHHCCCCHHH | 17.38 | - | |
106 | Phosphorylation | IDGGNSEYRDTTRRC EECCCHHHCCCCHHH | 17.38 | - | |
119 | Ubiquitination | RCRDLKAKGILFVGS HHHHHCCCCEEEEEC | 44.92 | 21890473 | |
119 | Ubiquitination | RCRDLKAKGILFVGS HHHHHCCCCEEEEEC | 44.92 | 21890473 | |
119 | 2-Hydroxyisobutyrylation | RCRDLKAKGILFVGS HHHHHCCCCEEEEEC | 44.92 | - | |
119 | Ubiquitination | RCRDLKAKGILFVGS HHHHHCCCCEEEEEC | 44.92 | 21906983 | |
126 | Phosphorylation | KGILFVGSGVSGGEE CCEEEEECCCCCCCC | 30.62 | 23403867 | |
129 | Phosphorylation | LFVGSGVSGGEEGAR EEEECCCCCCCCCCC | 44.60 | 25159151 | |
134 | Ubiquitination | GVSGGEEGARYGPSL CCCCCCCCCCCCCCC | 15.85 | - | |
141 | Acetylation | GARYGPSLMPGGNKE CCCCCCCCCCCCCCC | 5.59 | - | |
141 | Ubiquitination | GARYGPSLMPGGNKE CCCCCCCCCCCCCCC | 5.59 | - | |
141 | Acetylation | GARYGPSLMPGGNKE CCCCCCCCCCCCCCC | 5.59 | 19608861 | |
141 | Ubiquitination | GARYGPSLMPGGNKE CCCCCCCCCCCCCCC | 5.59 | 19608861 | |
142 | Sulfoxidation | ARYGPSLMPGGNKEA CCCCCCCCCCCCCCC | 3.21 | 30846556 | |
147 | Acetylation | SLMPGGNKEAWPHIK CCCCCCCCCCCHHHH | 52.67 | 7430939 | |
147 | Ubiquitination | SLMPGGNKEAWPHIK CCCCCCCCCCCHHHH | 52.67 | - | |
150 | Ubiquitination | PGGNKEAWPHIKTIF CCCCCCCCHHHHHHH | 6.01 | - | |
154 | Ubiquitination | KEAWPHIKTIFQGIA CCCCHHHHHHHHHHH | 32.31 | 21890473 | |
154 | Ubiquitination | KEAWPHIKTIFQGIA CCCCHHHHHHHHHHH | 32.31 | 21890473 | |
154 | Acetylation | KEAWPHIKTIFQGIA CCCCHHHHHHHHHHH | 32.31 | 23236377 | |
154 | Ubiquitination | KEAWPHIKTIFQGIA CCCCHHHHHHHHHHH | 32.31 | 21890473 | |
163 | Acetylation | IFQGIAAKVGTGEPC HHHHHHHHHCCCCCC | 31.98 | 25953088 | |
163 | Ubiquitination | IFQGIAAKVGTGEPC HHHHHHHHHCCCCCC | 31.98 | - | |
166 | Phosphorylation | GIAAKVGTGEPCCDW HHHHHHCCCCCCCCC | 41.16 | 25159151 | |
184 | Ubiquitination | EGAGHFVKMVHNGIE CCCHHHHHCCCCCCC | 33.97 | - | |
235 | Ubiquitination | LDSFLIEITANILKF HHHHHHHHHHHHHHE | 3.32 | - | |
248 | 2-Hydroxyisobutyrylation | KFQDTDGKHLLPKIR HEECCCCCCCCHHHH | 33.61 | - | |
248 | Acetylation | KFQDTDGKHLLPKIR HEECCCCCCCCHHHH | 33.61 | 25825284 | |
248 | Ubiquitination | KFQDTDGKHLLPKIR HEECCCCCCCCHHHH | 33.61 | - | |
252 | Ubiquitination | TDGKHLLPKIRDSAG CCCCCCCHHHHCCCC | 36.07 | - | |
253 | 2-Hydroxyisobutyrylation | DGKHLLPKIRDSAGQ CCCCCCHHHHCCCCC | 50.79 | - | |
253 | Ubiquitination | DGKHLLPKIRDSAGQ CCCCCCHHHHCCCCC | 50.79 | - | |
257 | Phosphorylation | LLPKIRDSAGQKGTG CCHHHHCCCCCCCCC | 25.17 | 24719451 | |
261 | Ubiquitination | IRDSAGQKGTGKWTA HHCCCCCCCCCCCHH | 58.48 | - | |
263 | Phosphorylation | DSAGQKGTGKWTAIS CCCCCCCCCCCHHHH | 42.49 | 18785766 | |
265 | Ubiquitination | AGQKGTGKWTAISAL CCCCCCCCCHHHHHH | 41.01 | - | |
281 | Ubiquitination | YGVPVTLIGEAVFAR HCCCEEEEHHHHHHH | 3.24 | - | |
291 | Phosphorylation | AVFARCLSSLKDERI HHHHHHHHCCCHHHH | 36.93 | 24719451 | |
292 | Phosphorylation | VFARCLSSLKDERIQ HHHHHHHCCCHHHHH | 26.87 | 24719451 | |
294 | Acetylation | ARCLSSLKDERIQAS HHHHHCCCHHHHHHH | 60.53 | 25953088 | |
294 | Ubiquitination | ARCLSSLKDERIQAS HHHHHCCCHHHHHHH | 60.53 | - | |
296 | Acetylation | CLSSLKDERIQASKK HHHCCCHHHHHHHHH | 50.53 | - | |
296 | Acetylation | CLSSLKDERIQASKK HHHCCCHHHHHHHHH | 50.53 | 19608861 | |
303 | Acetylation | ERIQASKKLKGPQKF HHHHHHHHCCCCCCC | 53.59 | - | |
303 | Ubiquitination | ERIQASKKLKGPQKF HHHHHHHHCCCCCCC | 53.59 | - | |
304 | Ubiquitination | RIQASKKLKGPQKFQ HHHHHHHCCCCCCCC | 9.97 | - | |
309 | 2-Hydroxyisobutyrylation | KKLKGPQKFQFDGDK HHCCCCCCCCCCCCH | 44.24 | - | |
309 | Acetylation | KKLKGPQKFQFDGDK HHCCCCCCCCCCCCH | 44.24 | 19608861 | |
309 | Ubiquitination | KKLKGPQKFQFDGDK HHCCCCCCCCCCCCH | 44.24 | 19608861 | |
316 | 2-Hydroxyisobutyrylation | KFQFDGDKKSFLEDI CCCCCCCHHHHHHHH | 56.71 | - | |
316 | Acetylation | KFQFDGDKKSFLEDI CCCCCCCHHHHHHHH | 56.71 | 23749302 | |
316 | Ubiquitination | KFQFDGDKKSFLEDI CCCCCCCHHHHHHHH | 56.71 | - | |
317 | 2-Hydroxyisobutyrylation | FQFDGDKKSFLEDIR CCCCCCHHHHHHHHH | 51.70 | - | |
317 | Acetylation | FQFDGDKKSFLEDIR CCCCCCHHHHHHHHH | 51.70 | 26822725 | |
317 | Ubiquitination | FQFDGDKKSFLEDIR CCCCCCHHHHHHHHH | 51.70 | - | |
318 | Phosphorylation | QFDGDKKSFLEDIRK CCCCCHHHHHHHHHH | 40.58 | 27050516 | |
324 | Methylation | KSFLEDIRKALYASK HHHHHHHHHHHHHHH | 30.43 | 115487209 | |
325 | 2-Hydroxyisobutyrylation | SFLEDIRKALYASKI HHHHHHHHHHHHHHH | 42.98 | - | |
334 | Phosphorylation | LYASKIISYAQGFML HHHHHHHHHHHHHHH | 20.21 | 23917254 | |
335 | Phosphorylation | YASKIISYAQGFMLL HHHHHHHHHHHHHHH | 7.79 | 23917254 | |
340 | Sulfoxidation | ISYAQGFMLLRQAAT HHHHHHHHHHHHHHH | 4.39 | 30846556 | |
364 | Ubiquitination | GIALMWRGGCIIRSV CEEEEEECCEEHHHH | 21.58 | - | |
375 | Acetylation | IRSVFLGKIKDAFDR HHHHHHHHHHHHHHC | 49.05 | 25953088 | |
377 | 2-Hydroxyisobutyrylation | SVFLGKIKDAFDRNP HHHHHHHHHHHHCCH | 46.63 | - | |
377 | Ubiquitination | SVFLGKIKDAFDRNP HHHHHHHHHHHHCCH | 46.63 | 21906983 | |
447 | Ubiquitination | ASLIQAQRDYFGAHT HHHHHHHHHHHCCCH | 43.54 | - | |
449 | Phosphorylation | LIQAQRDYFGAHTYE HHHHHHHHHCCCHHH | 13.20 | 28152594 | |
454 | Phosphorylation | RDYFGAHTYELLAKP HHHHCCCHHHHHCCC | 20.39 | 28796482 | |
455 | Phosphorylation | DYFGAHTYELLAKPG HHHCCCHHHHHCCCC | 8.50 | 28796482 | |
460 | Ubiquitination | HTYELLAKPGQFIHT CHHHHHCCCCCEEEC | 50.04 | - | |
467 | Phosphorylation | KPGQFIHTNWTGHGG CCCCEEECCCCCCCC | 27.86 | 29514088 | |
470 | Phosphorylation | QFIHTNWTGHGGTVS CEEECCCCCCCCCCC | 22.75 | 20068231 | |
475 | Phosphorylation | NWTGHGGTVSSSSYN CCCCCCCCCCCCCCC | 23.08 | 28450419 | |
477 | Phosphorylation | TGHGGTVSSSSYNA- CCCCCCCCCCCCCC- | 25.08 | 28796482 | |
478 | Phosphorylation | GHGGTVSSSSYNA-- CCCCCCCCCCCCC-- | 20.97 | 28796482 | |
479 | Phosphorylation | HGGTVSSSSYNA--- CCCCCCCCCCCC--- | 29.36 | 28796482 | |
480 | Phosphorylation | GGTVSSSSYNA---- CCCCCCCCCCC---- | 25.10 | 28464451 | |
481 | Phosphorylation | GTVSSSSYNA----- CCCCCCCCCC----- | 19.63 | 28796482 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
481 | Y | Phosphorylation | Kinase | FYN | P06241 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of 6PGD_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of 6PGD_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
AL7A1_HUMAN | ALDH7A1 | physical | 22863883 | |
AL9A1_HUMAN | ALDH9A1 | physical | 22863883 | |
EF2_HUMAN | EEF2 | physical | 22863883 | |
AGAL_HUMAN | GLA | physical | 22863883 | |
GNAI3_HUMAN | GNAI3 | physical | 22863883 | |
HMGB2_HUMAN | HMGB2 | physical | 22863883 | |
KS6A1_HUMAN | RPS6KA1 | physical | 22863883 | |
TXND5_HUMAN | TXNDC5 | physical | 22863883 | |
FABP5_HUMAN | FABP5 | physical | 26344197 | |
GDIA_HUMAN | GDI1 | physical | 26344197 | |
PDIA1_HUMAN | P4HB | physical | 26344197 | |
SUMO3_HUMAN | SUMO3 | physical | 26344197 | |
TALDO_HUMAN | TALDO1 | physical | 26344197 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00851 | Dacarbazine |
DB00695 | Furosemide |
DB00789 | Gadopentetate dimeglumine |
DB00920 | Ketotifen |
DB00814 | Meloxicam |
DB00563 | Methotrexate |
DB00867 | Ritodrine |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-38; LYS-59; LYS-76; LYS-154AND LYS-309, AND MASS SPECTROMETRY. |